Active NCI RFAs:  FY 2022  FY 2021  FY 2020 | Archive RFAs | Active PAs
Current and Recent Requests for Applications (RFA's)
RFA's that are active or have expired within the last 3 months (and associated notices)
 
2022 Trans-NIH Requests for Applications (RFA's)
RFA No. and TitleStatus - Expiration
DE22-004 Understanding Oral Human Papillomavirus (HPV) Infection, Acquisition, and Persistence in People Living with HIV (R21 Clinical Trial Not Allowed)ACTIVE - NOV 19, 2021
DE22-003 Understanding Oral Human Papillomavirus (HPV) Infection, Acquisition, and Persistence in People Living with HIV (R01 Clinical Trial Not Allowed)ACTIVE - NOV 19, 2021
NS22-002 HEAL Initiative: Advancing Health Equity in Pain Management (R61/R33 Clinical Trial Required)ACTIVE - DEC 10, 2021
 
 
 
 
2021 Requests for Applications (RFA's)
RFA No. and TitleStatus - Expiration
CA21-059 The NCI Predoctoral to Postdoctoral Fellow Transition Award (F99/K00 Clinical Trial Not Allowed)ACTIVE - NOV 19, 2021
CA21-058 Data, Evaluation and Coordinating Center for: A Multilevel Approach to Connecting Underrepresented Populations to Clinical Trials (CUSP2CT) (U24 Clinical Trial Not Allowed)ACTIVE - NOV 20, 2021
CA21-057 A Multilevel Approach to Connecting Underrepresented Populations to Clinical Trials (CUSP2CT U01 Clinical Trial Not Allowed)ACTIVE - NOV 20, 2021
CA21-056 Implementation Science for Cancer Control in People Living with HIV in Low- and Middle-Income Countries (U01 Clinical Trial Optional)ACTIVE - DEC 16, 2021
CA21-055 Translational and Basic Science Research in Early Lesions (TBEL) Coordinating and Data Management Center (U24 Clinical Trial Not Allowed)ACTIVE - NOV 03, 2021
CA21-054 Translational and Basic Science Research in Early Lesions (TBEL) (U54 Clinical Trial Not Allowed)ACTIVE - NOV 03, 2021
CA21-053 Coordinating and Data Management Center for Acquired Resistance to Therapy Network (ARTNet; U24 Clinical Trial Not Allowed)ACTIVE - NOV 02, 2021
CA21-052 Acquired Resistance to Therapy Network (ARTNet; U54 Clinical Trial Not Allowed)ACTIVE - NOV 02, 2021
CA21-051 Coordinating Center for Canine Cancer Immunotherapy Network (K9CIN; U24 Clinical Trial Not Allowed)EXPIRED - SEP 28, 2021
CA21-050 Canine Cancer Immunotherapy Network (K9CIN; U01 Clinical Trial Not Allowed)EXPIRED - SEP 28, 2021
CA21-049 Division of Cancer Biology Multi-Consortia Coordinating Center (U24 Clinical Trial Not Allowed)ACTIVE - NOV 13, 2021
CA21-048 Research Centers for Cancer Systems Biology (U54 Clinical Trial Not Allowed)ACTIVE - OCT 20, 2022
CA21-042 Pancreatic Ductal Adenocarcinoma Stromal Reprogramming Consortium Coordinating and Data Management Center (PSRC CDMC) (U24 Clinical Trial Not Allowed)ACTIVE - NOV 02, 2021
CA21-041 Pancreatic Ductal Adenocarcinoma (PDAC) Stromal Reprogramming Consortium (PSRC) (U01 Clinical Trial Not Allowed)ACTIVE - NOV 02, 2021
CA21-040 Radiation Oncology-Biology Integration Network (ROBIN) Centers (U54 Clinical Trial Required)ACTIVE - NOV 02, 2021
CA21-039 Cancer Prevention-Interception Targeted Agent Discovery Program (CAP-IT) Data and Resource Coordination Center (CAP-IT DRCC) (U24 Clinical Trial Not Allowed)EXPIRED - OCT 08, 2021
CA21-038 Cancer Prevention-Interception Targeted Agent Discovery Program (CAP-IT) Centers (U54 Clinical Trial Not Allowed)EXPIRED - OCT 08, 2021
CA21-037 3D Technologies to Accelerate HTAN Atlas Building Efforts (UH2 Clinical Trial Not Allowed)ACTIVE - NOV 23, 2021
CA21-036 SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer-Relevant Technologies Toward Commercialization (R44 Clinical Trial Optional)EXPIRED - AUG 07, 2021
CA21-035 The Early Detection Research Network: Biomarker Characterization Centers (U2C Clinical Trial Not Allowed)EXPIRED - SEP 10, 2021
CA21-034 The Early Detection Research Network: Data Management and Coordinating Center (U24 Clinical Trial Not Allowed)EXPIRED - SEP 10, 2021
CA21-033 The Early Detection Research Network: Clinical Validation Centers (U01 Clinical Trial Optional)EXPIRED - SEP 10, 2021
CA21-029 Centers on Telehealth Research for Cancer Related Care (P50 Clinical Trial Required)EXPIRED - JUL 21, 2021
CA21-027 Coordinating Center for the Program on the Origins of Gastroesophageal Cancers (U24 Clinical Trial Not Allowed)EXPIRED - OCT 09, 2021
CA21-026 Program on the Origins of Gastroesophageal Cancers (R01 Clinical Trial Optional)EXPIRED - OCT 09, 2021
CA21-025 Proteogenomic Translational Research Centers (PTRCs) for Clinical Proteomic Tumor Analysis Consortium (U01 Clinical Trial Not Allowed)EXPIRED - JUL 31, 2021
CA21-022 Coordinating Center for the Metabolic Dysregulation and Cancer Risk Program: A Transdisciplinary Approach to Obesity-Associated Cancer Research (U24 Clinical Trial Not Allowed)EXPIRED - OCT 07, 2021
CA21-021 Metabolic Dysregulation and Cancer Risk Program, Research Grants: a Transdisciplinary Approach to Obesity-Associated Research (U01 Clinical Trial Optional)EXPIRED - OCT 07, 2021
CA21-020 National Cancer Institute Youth Enjoy Science Research Education Program (R25 Clinical Trial Not Allowed)ACTIVE - SEP 29, 2023
CA21-019 Revision Applications to Support the Application of Informatics Technology for Cancer Research (U24 Clinical Trial Optional)ACTIVE - NOV 19, 2021
CA21-018 Revision Applications to Support the Application of Informatics Technology for Cancer Research (U01 Clinical Trials Optional)ACTIVE - NOV 18, 2021
CA21-017 Revision Applications to Support the Application of Informatics Technology for Cancer Research (R01 Clinical Trials Optional)ACTIVE - NOV 18, 2021
CA21-016 Sustained Support for Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)ACTIVE - NOV 18, 2021
CA21-015 Advanced Development of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)ACTIVE - NOV 18, 2021
CA21-014 Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional)ACTIVE - NOV 18, 2021
CA21-013 Development of Innovative Informatics Methods and Algorithms for Cancer Research and Management (R21 Clinical Trial Optional)ACTIVE - NOV 18, 2021
CA21-012 Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P50 Clinical Trial Optional)EXPIRED - SEP 30, 2021
CA21-011 Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P01 Clinical Trial Optional)EXPIRED - SEP 30, 2021
CA21-010 Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U2C Clinical Trial Optional)EXPIRED - SEP 30, 2021
CA21-009 Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U54 Clinical Trial Optional)EXPIRED - SEP 30, 2021
CA21-008 Revision Applications for Incorporation of Novel NCI- Supported Technology to Accelerate Cancer Research (U01 Clinical Trial Optional)EXPIRED - SEP 30, 2021
CA21-007 Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (R01 Clinical Trial Optional)EXPIRED - SEP 30, 2021
CA21-006 Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)EXPIRED - SEP 30, 2021
CA21-005 Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research (R21 Clinical Trial Not Allowed)EXPIRED - SEP 30, 2021
CA21-004 Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)EXPIRED - SEP 29, 2021
CA21-003 Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R21 Clinical Trial Not Allowed)EXPIRED - SEP 30, 2021
 
2021 Trans-NIH Requests for Applications (RFA's)
RFA No. and TitleStatus - Expiration
HG21-037 Limited Competition: Knockout Mouse Phenotyping Project Data Coordination Center and Database (UM1 Clinical Trial Not Allowed)ACTIVE - NOV 02, 2021
HG21-036 Limited Competition: Knockout Mouse Production and Phenotyping Project (UM1) Clinical Trial Not AllowedACTIVE - NOV 02, 2021
HG21-001 Technology Development for Single-Molecule Protein Sequencing (R01 Clinical Trial not allowed)ACTIVE - JUN 16, 2023
MD21-004 Understanding and Addressing the Impact of Structural Racism and Discrimination on Minority Health and Health Disparities (R01 Clinical Trial Optional)EXPIRED - AUG 25, 2021
OD21-007 INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE (INCLUDE) Exploratory/Developmental Research Grant Award (R21 Clinical Trial Not Allowed)ACTIVE - NOV 04, 2022
OD21-004 Maximizing the Scientific Value of Existing Biospecimen Collections (R21 Clinical Trial Not Allowed)ACTIVE - MAR 09, 2023
OD21-003 Secondary Analyses of Existing Datasets of Tobacco Use and Health (R21 Clinical Trial Not Allowed)ACTIVE - MAR 09, 2023
OD21-002 Tobacco Regulatory Science (R01 Clinical Trial Optional)ACTIVE - FEB 15, 2023
RM21-025 NIH Faculty Institutional Recruitment for Sustainable Transformation (FIRST) Program: FIRST Cohort (U54 Clinical Trial Optional)EXPIRED - SEP 25, 2021
TW21-004 Launching Future Leaders in Global Health (LAUNCH) Research Training Program (D43 Clinical Trial Optional)EXPIRED - AUG 21, 2021
 
 
 
 
2020 Requests for Applications (RFA's)
RFA No. and TitleStatus - Expiration
CA20-051 Social and Behavioral Intervention Research to Address Modifiable Risk Factors for Cancer in Rural Populations (R01 Clinical Trial Required)ACTIVE - JAN 19, 2022
CA20-046 Investigation of the Transmission of Kaposi Sarcoma-Associated Herpesvirus (KSHV) (R01 Clinical Trial Optional)ACTIVE - DEC 15, 2021
CA20-028 Research to Reduce Morbidity and Improve Care for Pediatric, and Adolescent and Young Adult (AYA) Cancer Survivors (R21 Clinical Trial Optional)EXPIRED - JUL 31, 2021
CA20-027 Research to Reduce Morbidity and Improve Care for Pediatric, and Adolescent and Young Adult (AYA) Cancer Survivors (R01 Clinical Trial Optional)EXPIRED - JUL 31, 2021
 
2020 Trans-NIH Requests for Applications (RFA's)
RFA No. and TitleStatus - Expiration
HL20-006 Stimulating Access to Research in Residency Transition Scholar (StARRTS) (K38) (Clinical Trial Not Allowed)ACTIVE - JAN 15, 2022
NS20-011 HEAL INITIATIVE: Development of Therapies and Technologies Directed at Enhanced Pain Management (R43/R44 - Clinical Trial Not Allowed)ACTIVE - SEP 09, 2022
NS20-010 HEAL INITIATIVE: Development of Therapies and Technologies Directed at Enhanced Pain Management (R43/R44 - Clinical Trial Required)ACTIVE - SEP 09, 2022
NS20-009 HEAL Initiative: Development of Therapies and Technologies Directed at Enhanced Pain Management (R41/R42 Clinical Trial Not Allowed)ACTIVE - SEP 09, 2022
NS20-008 HEAL Initiative: Development of Therapies and Technologies Directed at Enhanced Pain Management (R41/R42 Clinical Trial Required)ACTIVE - SEP 09, 2022
OD20-011 Mentored Research Scientist Career Development Award in Tobacco Regulatory Research (K01 - Independent Clinical Trial Required)ACTIVE - JUL 11, 2022
OD20-010 Pathway to Independence Award in Tobacco Regulatory Research (K99/R00 - Independent Clinical Trial Required)ACTIVE - JUL 11, 2022
OD20-009 Pathway to Independence Award in Tobacco Regulatory Research (K99/R00 - Independent Clinical Trial Not Allowed)ACTIVE - JUL 11, 2022
OD20-008 Mentored Research Scientist Career Development Award in Tobacco Regulatory Research (K01 - Independent Clinical Trial Not Allowed)ACTIVE - JUL 11, 2022